Ligand-antisense conjugate

Ionis, Inc. has begun full-scale commercialization of a ligand-antisense conjugate (LICA). Following the commercialization of antibody conjugates（ADCs）, ensemble drug discovery has taken off.
https://miyata-bio.net/column/0000363/